Autolus Therapeutics PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Autolus Therapeutics PLC
TickerAUTL
CIK #0001730463
CUSIP05280R100
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressForest House, 58 Wood Lane White City, London, W12 7RZ
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Autolus Therapeutics PLC 2024-02-23 200.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001730463] 10-K
[0001730463] 10-Q
[0001730463] 3
[0001730463] 4
[0001730463] 6-K
[0001730463] 8-K
[0001730463] D
[0001730463] SC 13D
[0001730463] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Armistice Capital LLC Autolus Therapeutics PLC [2025-11-14] 0.0
Mak Capital Fund LP Autolus Therapeutics PLC [2025-06-25] 0.0
FMR LLC Autolus Therapeutics PLC [2024-11-12] 0.0
Wellington Management Group LLP Autolus Therapeutics PLC [2024-11-08] 0.11
Biontech SE Autolus Therapeutics PLC [2024-02-21] 819412.5
Paradigm Biocapital Advisors LP Autolus Therapeutics PLC [2023-07-10] 5.8
Tetragon Financial Management LP Autolus Therapeutics PLC [2023-03-20] 5.5
Armistice Capital LLC Autolus Therapeutics PLC [2023-02-14] 5.91
Deep Track Capital LP Autolus Therapeutics PLC [2022-12-19] 0.03
Qatar Investment Authority Autolus Therapeutics PLC [2022-12-13] 0.03
Nantahala Capital Management LLC Autolus Therapeutics PLC [2022-02-14] 5.6
Frazier Life Sciences Public Fund LP Autolus Therapeutics PLC [2021-12-17] 4.1
Blackstone Inc Autolus Therapeutics PLC [2021-11-16] 22.6
Capital World Investors Autolus Therapeutics PLC [2021-02-16] 5.7
Kellner Petr Autolus Therapeutics PLC [2020-01-24] 21.0
PPF Cyprus Management Ltd Autolus Therapeutics PLC [2019-09-16] 19.2
Woodford Patient Capital Trust PLC Autolus Therapeutics PLC [2019-02-14] 10.2
Syncona Portfolio Ltd Autolus Therapeutics PLC [2019-02-13] 33.9
LF Woodford Equity Income Fund Autolus Therapeutics PLC [2018-07-10] 6.9
Woodford Investment Management Ltd Autolus Therapeutics PLC [2018-07-10] 24.1
Arix Bioscience PLC Autolus Therapeutics PLC [2018-07-06] 7.9
Form 3/4/5 Filer 2011 - 2026
Autolus Therapeutics PLC
Bain Linda
Iannone Robert
Leiderman Elisabeth
Butitta Cynthia M
Richardson Ryan
Rao Madduri Ravin
Young William D
Bonney Michael W
Azelby Robert
Dolski Robert
Piccina Cintia
Swan Alexander
McIlvenny Patrick Paul
Vann Christopher Andrew
Williams Christopher Michael James
Pule Martin Anton
Will Matthias
Neville Miranda Suzette
Berriman John E
Itin Christian
Driggs Alex
13F Ownership Over TimeHoldersShares Held
2026-03-31 84 134,802,841
2025-12-31 89 137,684,245
2025-09-30 96 143,657,339
2025-06-30 94 163,356,599
2025-03-31 96 168,182,860
2024-12-31 111 165,628,048
2024-09-30 102 176,106,961
2024-06-30 112 174,329,808
2024-03-31 121 171,883,741
2023-12-31 100 113,146,929
2023-09-30 73 110,918,021
2023-06-30 71 109,522,670
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 451,403 451,403
Quantum Financial Partners LLC [2026-06-30] SOLE 0 18,795
QRG Capital Management Inc [2026-06-30] SOLE 18,325 18,325
Gamma Investing LLC [2026-06-30] DFND 15,499 15,499
Byrne Asset Management LLC [2026-06-30] SOLE 100 100
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com